Would you recommend decreasing dose to the whole breast and nodes if constraints cannot be met?

For breast would not decrease dose but would block area of breast if feel risk of microscopic disease low to achieve normal tissue dosimetry

For prophylactic treatment of IM node have decreased dose to 40 gy for coverage or even excluded them if lung and heart dose a concern